409 related articles for article (PubMed ID: 8670870)
1. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.
Voegel JJ; Heine MJ; Zechel C; Chambon P; Gronemeyer H
EMBO J; 1996 Jul; 15(14):3667-75. PubMed ID: 8670870
[TBL] [Abstract][Full Text] [Related]
2. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.
Le Douarin B; Nielsen AL; Garnier JM; Ichinose H; Jeanmougin F; Losson R; Chambon P
EMBO J; 1996 Dec; 15(23):6701-15. PubMed ID: 8978696
[TBL] [Abstract][Full Text] [Related]
3. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
Voegel JJ; Heine MJ; Tini M; Vivat V; Chambon P; Gronemeyer H
EMBO J; 1998 Jan; 17(2):507-19. PubMed ID: 9430642
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR
Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670
[TBL] [Abstract][Full Text] [Related]
6. SLIRP, a small SRA binding protein, is a nuclear receptor corepressor.
Hatchell EC; Colley SM; Beveridge DJ; Epis MR; Stuart LM; Giles KM; Redfern AD; Miles LE; Barker A; MacDonald LM; Arthur PG; Lui JC; Golding JL; McCulloch RK; Metcalf CB; Wilce JA; Wilce MC; Lanz RB; O'Malley BW; Leedman PJ
Mol Cell; 2006 Jun; 22(5):657-68. PubMed ID: 16762838
[TBL] [Abstract][Full Text] [Related]
7. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).
Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the repertoire of nuclear receptor binding sites in genomes.
Cotnoir-White D; Laperrière D; Mader S
Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
[TBL] [Abstract][Full Text] [Related]
9. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation.
Wärnmark A; Treuter E; Wright AP; Gustafsson JA
Mol Endocrinol; 2003 Oct; 17(10):1901-9. PubMed ID: 12893880
[TBL] [Abstract][Full Text] [Related]
10. Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes.
Treuter E; Johansson L; Thomsen JS; Wärnmark A; Leers J; Pelto-Huikko M; Sjöberg M; Wright AP; Spyrou G; Gustafsson JA
J Biol Chem; 1999 Mar; 274(10):6667-77. PubMed ID: 10037764
[TBL] [Abstract][Full Text] [Related]
11. Identification of mouse TRAP100: a transcriptional coregulatory factor for thyroid hormone and vitamin D receptors.
Zhang J; Fondell JD
Mol Endocrinol; 1999 Jul; 13(7):1130-40. PubMed ID: 10406464
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.
Le Douarin B; Zechel C; Garnier JM; Lutz Y; Tora L; Pierrat P; Heery D; Gronemeyer H; Chambon P; Losson R
EMBO J; 1995 May; 14(9):2020-33. PubMed ID: 7744009
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
Wang Z; Benoit G; Liu J; Prasad S; Aarnisalo P; Liu X; Xu H; Walker NP; Perlmann T
Nature; 2003 May; 423(6939):555-60. PubMed ID: 12774125
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2.
Leers J; Treuter E; Gustafsson JA
Mol Cell Biol; 1998 Oct; 18(10):6001-13. PubMed ID: 9742117
[TBL] [Abstract][Full Text] [Related]
16. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.
Takeshita A; Cardona GR; Koibuchi N; Suen CS; Chin WW
J Biol Chem; 1997 Oct; 272(44):27629-34. PubMed ID: 9346901
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation.
Kato S; Yokoyama A; Fujiki R
Trends Biochem Sci; 2011 May; 36(5):272-81. PubMed ID: 21315607
[TBL] [Abstract][Full Text] [Related]
18. Role of the essential yeast protein PSU1 in p6anscriptional enhancement by the ligand-dependent activation function AF-2 of nuclear receptors.
Gaudon C; Chambon P; Losson R
EMBO J; 1999 Apr; 18(8):2229-40. PubMed ID: 10205176
[TBL] [Abstract][Full Text] [Related]
19. [Nuclear receptor-mediated signaling pathway].
Kato S
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):133-40. PubMed ID: 11031742
[TBL] [Abstract][Full Text] [Related]
20. XTIF2, a Xenopus homologue of the human transcription intermediary factor, is required for a nuclear receptor pathway that also interacts with CBP to suppress Brachyury and XMyoD.
de la Calle-Mustienes E; Gómez-Skarmeta JL
Mech Dev; 2000 Mar; 91(1-2):119-29. PubMed ID: 10704837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
